No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
533 |
4. Check minimum number of eventsNone |
533 |
5. Include endpointsNone |
533 |
6. Filter based on genotype QC (FinnGen only) |
533 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M34
- Name in latin
- Syndroma CREST
Similar endpoints
↥List of similar endpoints to
CR(E)ST syndrome
based on the number of shared cases.
Similar with more cases:
- Systemic sclerosis, icd10
- Systemic sclerosis
- Systemic sclerosis (FG)
- Systemic connective tissue disorders
- Finngen Rheumatological endpoints
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2272 | 1946 | 313 |
| Only index persons | 2112 | 1834 | 278 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.01 |
| Only index persons | 0.06 | 0.07 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 58.34 | 58.28 | 59.14 |
| Only index persons | 57.94 | 57.80 | 58.89 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 533 | 467 | 66 |
| Unadjusted period prevalence (%) | 0.14 | 0.16 | 0.03 |
| Median age at first event (years) | 56.74 | 56.79 | 56.38 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 479
- Matched controls
- 4788
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
323.0
479
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
23.3
186.8
313
358
C08CA05
ATC
nifedipine; systemic
34.9
180.5
244
138
P01BA02
ATC
hydroxychloroquine; oral
21.0
165.0
277
293
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
447.3
136.1
130
*
I73.0
ICD-10 Finland
Raynaud syndrome
61.8
122.1
141
32
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
10.3
87.9
198
306
XX9XE
NOMESCO Finland
Other ultrasound examination
54.3
81.1
96
22
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
10.6
68.6
145
188
M34.0
ICD-10 Finland
Progressive systemic sclerosis
734.2
66.6
64
*
XPX04
NOMESCO Finland
Angioscopy
114.9
64.8
69
7
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
41.5
64.1
80
23
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
8.1
60.6
153
262
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.8
54.5
258
938
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
5.2
52.2
202
586
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
11.1
50.1
100
111
L04AA06
ATC
mycophenolic acid; systemic
29.9
48.3
65
25
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
10.5
47.2
97
113
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.9
43.8
305
1475
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
241.6
43.7
44
*
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
217.7
39.5
40
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
13.3
34.2
61
52
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
11.1
32.0
62
63
XG410
NOMESCO Finland
Flow-volume spirometry
10.1
30.8
63
71
L88
ICPC
Rheumatoid/seropositive arthritis
8.3
30.3
70
97
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
4.9
30.0
108
267
L04AX01
ATC
azathioprine; systemic
8.1
29.9
70
99
M35.1
ICD-10 Finland
Other overlap syndromes
53.7
29.8
35
7
G04BE03
ATC
sildenafil; oral
60.8
29.5
34
6
H02AB06
ATC
prednisolone; systemic
2.8
26.0
289
1674
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.0
25.4
88
207
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
12.3
25.2
46
41
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
263.2
24.9
25
*
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
36.7
24.6
31
9
C08CA02
ATC
felodipine; oral
4.4
21.9
85
223
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
10.0
21.8
44
48
NH3EA
NOMESCO Finland
Feet X-ray examination with load
9.2
20.4
43
51
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.8
20.4
94
288
K74.3
ICD-10 Finland
Primary biliary cirrhosis
30.4
19.8
26
9
C08CA01
ATC
amlodipine; oral
2.5
19.4
212
1147
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
8.1
19.4
44
59
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
19.2
234
1340
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
19.7
18.9
28
15
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.2
18.8
76
206
M34
ICD-10 Finland
Systemic sclerosis
197.4
18.7
19
*
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
12.7
17.6
31
26
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.0
17.5
115
453
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
8.8
16.8
36
44
R06.0
ICD-10 Finland
Dyspnoea
2.5
16.6
161
802
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.2
15.9
257
1635
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
12.3
15.8
28
24
C02KX01
ATC
bosentan; oral
165.2
15.6
16
*
A05AA02
ATC
ursodeoxycholic acid; oral
9.9
15.2
30
32
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
6.8
15.1
38
60
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.7
15.0
70
214
M01CC01
ATC
penicillamine; oral
58.6
14.9
17
*
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
26.0
14.8
20
8
H04.10
ICD-10 Finland
Dry eye syndrome
3.2
14.1
79
278
SBA10
NOMESCO Finland
Measurement of excretion of saliva
14.1
13.9
23
17
E0000UV
ATC
NA
2.1
13.8
231
1460
C02KX04
ATC
macitentan; oral
+∞
13.6
13
*
R4120
NOMESCO Finland
Occupational therapy
3.8
13.5
59
171
L04AD01
ATC
ciclosporin; systemic
9.5
13.4
27
30
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
19.7
13.0
19
10
RT172
NOMESCO Finland
NA
51.5
12.9
15
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.4
12.8
47
116
XQ860
NOMESCO Finland
Laser Doppler measurement/scan of capillary perfusion
+∞
12.6
12
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.3
12.1
63
210
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
11.9
223
1450
GD1AD
NOMESCO Finland
Thorax CT examination
5.1
11.7
37
78
RT160
NOMESCO Finland
NA
66.6
11.7
13
*
TGC00
NOMESCO Finland
Bronchial lavation
7.0
11.6
28
42
7101A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic sclerosis[SCLERODERMA]
+∞
11.5
11
*
K62.3
ICD-10 Finland
Rectal prolapse
10.4
11.1
21
21
WZA10
NOMESCO Finland
Long statement of health and health related matters
10.4
11.1
21
21
D06BX01
ATC
metronidazole; topical
2.7
11.1
82
344
NHQ40
NOMESCO Finland
Amputation of toe
13.3
10.7
18
14
L03.0
ICD-10 Finland
Cellulitis of finger and toe
3.5
10.7
50
154
L04AA01
ATC
[U] ciclosporin; systemic
10.4
10.6
20
20
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
10.5
65
245
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
+∞
10.5
10
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.7
10.3
45
131
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.7
10.2
44
127
J01FF01
ATC
clindamycin; systemic
2.0
10.1
161
967
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.2
10.0
53
180
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
9.8
127
700
A02BC02
ATC
pantoprazole; systemic
1.9
9.8
340
2688
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
9.7
112
587
I27.0
ICD-10 Finland
Primary pulmonary hypertension
56.2
9.7
11
*
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
102.0
9.4
10
*
K22.7
ICD-10 Finland
Barrett oesophagus
11.0
9.4
17
16
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
11.8
9.1
16
14
R13
ICD-10 Finland
Dysphagia
3.1
9.0
48
164
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
9.7
8.8
17
18
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
9.7
8.8
17
18
A02BC01
ATC
omeprazole; systemic
1.9
8.6
149
911
RT274
NOMESCO Finland
NA
16.6
8.6
13
8
K22.1
ICD-10 Finland
Ulcer of oesophagus
8.1
8.4
18
23
C02DE02
ATC
NA
11.0
8.3
15
14
RT272
NOMESCO Finland
NA
11.0
8.3
15
14
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.4
8.2
28
66
UJF32
NOMESCO Finland
Coloscopy
1.9
8.1
141
860
R15
ICD-10 Finland
Faecal incontinence
4.3
8.1
29
71
A10BA02
ATC
metformin; oral
0.4
8.1
35
797
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.7
7.9
33
93
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
13.3
7.9
13
10
ZX120
NOMESCO Finland
Intravenous
2.6
7.9
59
247
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.7
7.8
33
94
SPAT1263
SPAT
Sampling
1.8
7.8
211
1486
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
9.6
7.8
15
16
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
9.6
7.8
15
16
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
7.7
204
1424
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
5.3
7.6
22
43
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
12.1
7.6
13
11
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
7.6
48
183
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.7
7.5
52
210
A02BC05
ATC
esomeprazole; systemic
1.7
7.5
221
1596
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
4.1
7.4
27
68
M31.4
ICD-10 Finland
Aortic arch syndrome [Takayasu]
+∞
7.3
7
*
UJF30
NOMESCO Finland
Ileoscopy through colon
2.4
7.2
61
273
J01AA04
ATC
lymecycline; systemic
2.2
7.2
77
387
RT231
NOMESCO Finland
NA
30.5
7.2
9
*
RT310
NOMESCO Finland
NA
20.4
7.2
10
5
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.3
7.2
64
297
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
4.0
7.1
27
71
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.5
7.1
31
92
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.1
7.1
21
43
C08DB01
ATC
diltiazem; oral
3.5
7.0
31
93
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
7.0
107
622
A02BC03
ATC
lansoprazole; oral
1.8
7.0
156
1028
RT271
NOMESCO Finland
NA
14.0
6.9
11
8
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
6.9
96
538
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
6.9
189
1326
M05BX04
ATC
denosumab; parenteral
3.0
6.8
39
139
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.5
6.8
19
36
SPAT1312
SPAT
General health counselling
1.8
6.8
155
1026
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.3
6.8
63
295
NGQ20
NOMESCO Finland
Amputation of lower leg
40.6
6.8
8
*
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
40.6
6.8
8
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.3
6.7
63
298
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
6.7
70
349
SPAT1255
SPAT
Intravenous administration of medicine
3.1
6.7
35
119
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
22.9
6.7
9
*
NDQ20
NOMESCO Finland
Amputation of finger
22.9
6.7
9
*
K76.9
ICD-10 Finland
Liver disease, unspecified
6.6
6.7
16
25
S09
ICPC
Infected finger/toe
4.2
6.7
24
60
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
6.6
58
267
H02AB07
ATC
prednisone; oral
2.1
6.6
81
432
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
6.5
68
336
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
6.5
148
977
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.4
6.5
22
52
J01MA12
ATC
levofloxacin; systemic
2.0
6.5
86
474
ADA20
NOMESCO Finland
Thoracal sympathectomy
70.8
6.4
7
*
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
5.0
6.4
19
39
EBA10
NOMESCO Finland
Surgical removal of tooth
2.5
6.4
50
214
J01AA07
ATC
tetracycline; systemic
2.0
6.4
83
451
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
9.4
6.3
12
13
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.8
6.3
40
153
383
Kela drug reimbursment
Selexipag
+∞
6.3
6
*
B01AC27
ATC
selexipag; oral
+∞
6.3
6
*
G73.7*M34.8
ICD-10 Finland
Myopathy in scleroderma
+∞
6.3
6
*
RT171
NOMESCO Finland
NA
27.1
6.2
8
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
6.2
340
2847
L95
ICPC
Osteoporosis
3.3
6.1
29
92
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
6.1
56
262
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
6.0
45
189
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
257
157
30.68
307.65
1.6
1.2
u/ml
4.6
16.3
—
16
10
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
237
108
38.71
307.65
1.5
1.3
u/ml
18.5
13.5
—
32
7
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
254
143
33.02
307.65
1.6
1.2
u/ml
2.6
2.3
0.11
68
15
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
254
145
32.55
307.65
1.7
1.2
u/ml
4.8
6.8
0.23
96
25
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
204
119
27.15
262.69
1.7
1.2
u/ml
28.1
44.0
0.38
34
14
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
177
108
24.04
221.35
1.5
1.2
u/ml
0.4
—
—
8
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
199
169
18.20
209.10
2.3
1.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
185
192
14.23
169.64
1.7
1.3
u/ml
7.9
1.0
3.04
17
11
(3037522) Nuclear Ab [Titer] in Serum
314
673
9.92
161.82
1.8
1.3
titre
2077.2
488.7
29.53
240
157
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
161
144
15.59
161.73
2.0
1.7
g/l
0.2
0.2
4.66
151
139
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
161
152
14.74
156.15
2.0
1.6
g/l
1.0
1.2
6.63
151
147
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
410
1236
11.04
151.39
4.7
2.8
ng/l
630.3
954.9
2.06
384
1028
(3013293) Extractable nuclear Ab [Presence] in Serum
71
10
81.76
132.61
1.6
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
69
17
46.48
115.64
2.6
1.2
ug/l
8.6
9.0
0.16
69
17
(3001604) Monocytes [#/volume] in Blood
494
2291
16.80
105.22
12.3
5.6
e9/l
0.6
0.6
0.02
485
1974
(3006315) Basophils [#/volume] in Blood
495
2302
17.13
105.11
12.4
5.6
e9/l
0.0
0.0
0.83
486
1982
(3013115) Eosinophils [#/volume] in Blood
498
2379
17.65
101.27
12.6
6.0
e9/l
0.2
0.2
1.02
488
2092
(3019198) Lymphocytes [#/volume] in Blood
493
2353
15.59
99.47
12.5
5.6
e9/l
1.6
1.9
6.10
482
2072
(3013650) Neutrophils [#/volume] in Blood by Automated count
496
2681
13.25
78.49
14.8
9.0
e9/l
3.7
4.0
2.17
487
2358
(42870588) Differential panel, method unspecified - Blood
364
1525
5.37
76.84
11.3
5.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
444
2190
7.15
76.78
12.1
5.6
%
57.9
56.9
1.28
439
2043
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
64
40
18.05
76.50
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
64
40
18.05
76.50
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
64
40
18.05
76.50
1.2
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
445
2209
7.14
76.07
12.6
5.8
%
27.6
28.6
1.61
440
2046
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
64
41
17.60
75.54
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
64
41
17.60
75.54
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
64
41
17.60
75.54
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
151
311
6.38
74.04
3.8
2.7
ng/l
97.6
136.8
1.17
146
287
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
319
1358
4.36
61.83
2.5
2.1
u/l
103.0
213.1
1.55
309
1283
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
57
43
14.72
61.40
1.3
1.1
u/ml
15.3
79.0
—
13
6
(3004616) Nuclear Ab [Presence] in Serum
65
63
11.61
59.96
1.5
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
145
352
5.29
58.29
3.4
2.9
g/l
9.6
10.2
0.69
134
324
(40760892) CBC W Ordered Manual Differential panel - Blood
263
1049
3.98
54.22
7.5
4.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
134
337
4.98
51.16
4.5
4.5
%
0.0
1.2
0.60
21
85
(3002179) Metamyelocytes/100 leukocytes in Blood
134
345
4.85
49.61
4.3
4.3
%
0.4
0.6
0.49
20
82
(3021440) Promyelocytes/100 leukocytes in Blood
136
359
4.74
48.75
4.5
4.4
%
0.1
0.2
0.88
26
104
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
37
19
20.85
48.00
1.1
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
139
381
4.58
47.41
4.6
4.3
%
0.7
1.2
0.97
26
116
(3013707) Erythrocyte sedimentation rate by Westergren method
516
3528
15.50
47.05
11.1
4.2
mm/h
12.2
12.2
0.04
509
3256
(3035350) Ketones [Presence] in Urine by Test strip
400
2277
4.03
45.29
5.8
3.7
estimate
0.0
0.0
0.00
116
431
(3037467) Urinalysis macro (dipstick) panel - Urine
482
3184
6.37
43.27
8.3
4.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
399
2307
3.90
43.18
7.1
4.9
estimate
0.0
0.0
0.50
119
428
(3009261) Glucose [Presence] in Urine by Test strip
399
2326
3.85
42.19
5.8
3.7
estimate
0.0
0.0
0.80
121
417
(3026493) Urate [Moles/volume] in Serum or Plasma
253
1132
3.35
41.04
2.9
2.4
umol/l
825.7
7550.3
4.38
238
963
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
363
2088
3.32
37.15
3.0
2.2
nmol/l
82.0
78.8
1.36
337
1859
(3030905) Polymorphonuclear cells [#/volume] in Blood
58
93
6.88
35.42
3.1
3.1
e9/l
3.8
4.8
2.31
58
93
(3028026) IgM [Mass/volume] in Serum or Plasma
105
290
4.26
34.75
1.7
1.7
g/l
1.6
1.4
0.84
93
264
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
58
97
6.59
34.00
3.2
3.5
%
57.4
60.8
1.04
58
97
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
372
2263
3.13
32.72
7.3
6.1
mmol/l
1.2
1.2
1.85
308
1907
(3007566) Smooth muscle Ab [Titer] in Serum
61
113
5.97
32.25
1.2
1.2
titre
75.0
80.0
—
6
12
(3021589) Normoblasts [#/volume] in Blood
348
2062
2.98
31.70
16.5
8.8
e9/l
0.0
0.0
0.16
329
1697
(3034770) Mitochondria Ab [Titer] in Serum
62
120
5.72
31.28
1.3
1.2
titre
1109.2
658.6
—
12
7
(3006184) Hemoglobin [Mass/volume] in Capillary blood
55
95
6.34
31.19
1.7
1.9
g/l
116.9
130.9
1.96
15
67
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
347
2077
2.92
30.57
6.8
5.3
mmol/l
1.2
1.2
1.25
322
1883
(3029937) Albumin [Presence] in Urine by Test strip
244
1236
2.80
29.35
6.9
4.1
estimate
0.0
0.0
0.80
122
425
(40768797) Stomach Pathology biopsy report
168
705
3.02
28.62
1.3
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
280
1558
2.68
27.46
4.1
3.5
e6/l
53.9
67.7
0.29
193
1066
(3000492) Spirometry study
117
413
3.35
26.57
2.3
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
197
948
2.71
25.48
1.3
1.3
iu/ml
40.7
33.5
0.24
87
312
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
20
11
18.85
24.83
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
20
11
18.85
24.83
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
20
11
18.85
24.83
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
20
11
18.85
24.83
1.1
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
121
466
3.07
23.53
2.2
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
207
1054
2.58
23.51
6.1
3.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
250
1401
2.48
23.00
4.4
3.5
ph
7.4
7.4
2.53
60
270
(3007164) IgA [Mass/volume] in Serum or Plasma
190
952
2.55
22.07
1.6
1.5
g/l
2.2
2.3
0.29
122
561
(4268621)
31
44
7.42
20.99
2.1
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
288
1774
2.36
20.75
6.4
3.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
36
64
5.96
19.71
1.4
1.2
u/ml
6.9
1.5
0.53
14
17
(3022948) Iron [Moles/volume] in Serum or Plasma
143
660
2.59
19.38
3.5
2.1
umol/l
11.1
13.0
2.24
136
610
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
126
553
2.67
18.86
3.5
2.2
%
20.2
22.2
0.74
110
472
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
200
1088
2.34
18.81
3.9
2.1
mg/l
3.1
3.1
0.01
183
916
(3000850) Epithelial cells [#/volume] in Urine
174
893
2.41
18.68
3.0
2.4
e6/l
3.6
6.9
2.51
166
799
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
102
406
2.87
18.38
2.9
2.1
g/l
0.2
0.2
1.90
94
389
(3024561) Albumin [Mass/volume] in Serum or Plasma
293
1916
2.18
17.08
6.0
4.1
g/l
35.5
35.9
0.56
278
1787
(3030467) Casts [#/volume] in Urine by Automated count
206
1183
2.21
16.59
3.4
2.8
e6/l
0.2
0.4
1.19
178
871
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
34
69
5.20
16.15
1.3
1.1
u/ml
3.9
7.3
0.39
15
26
(3004789) Transferrin [Mass/volume] in Serum or Plasma
127
600
2.47
16.08
3.5
2.1
g/l
2.4
2.4
0.41
121
558
(36304419) Bacteria [Presence] in Urine
202
1179
2.15
15.37
3.4
2.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
264
1718
2.06
14.91
8.5
7.4
inr
1.2
1.2
0.01
92
508
(3041096) Erythrocytes [Presence] in Urine by Automated
211
1264
2.11
14.90
4.6
3.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
101
445
2.57
14.73
1.5
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
166
912
2.19
14.61
1.3
1.3
u/ml
19.4
11.2
0.53
67
332
(3004588) Protein electrophoresis panel - Serum or Plasma
80
319
2.77
14.20
2.0
2.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
30
62
5.07
13.96
1.7
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
128
644
2.30
13.87
2.3
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
210
1286
2.04
13.73
3.3
2.9
e6/l
22.5
50.1
0.95
184
967
(3020630) Protein [Mass/volume] in Serum or Plasma
85
356
2.65
13.69
2.1
2.7
g/l
65.1
67.1
1.39
79
326
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
522
4605
7.47
13.52
26.3
12.9
mg/l
17.3
21.3
2.26
446
3570
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
45
134
3.58
13.04
1.9
1.6
iu/ml
0.1
0.2
—
9
18
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
21
33
6.58
12.91
1.5
1.4
%
40.5
47.9
0.25
11
18
(40758558) Short blood count panel - Blood
198
1210
2.01
12.84
9.8
6.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
37
98
3.98
12.66
1.6
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
112
552
2.30
12.64
1.5
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
178
1059
2.02
12.36
4.7
3.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
133
711
2.16
12.28
2.8
2.5
e6/l
0.6
1.2
3.55
101
380
(3042936) Bacteria identified in Isolate by Culture
118
610
2.20
11.81
2.7
2.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
45
143
3.34
11.80
1.5
1.3
ug/g
277.6
313.9
0.51
24
81
(40761535) Cells panel - Urine sediment
82
362
2.50
11.79
6.7
3.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
14
15
9.56
11.70
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
248
1675
1.90
11.69
4.4
3.3
ng/l
24.3
50.9
0.64
179
1115
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
37
104
3.75
11.66
1.6
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
92
432
2.37
11.55
2.4
2.7
%
1.9
1.8
0.25
83
385
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
25
53
4.90
11.29
1.8
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
53
4.90
11.29
1.8
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
180
1107
1.95
11.16
1.3
1.3
u/ml
0.5
1.6
1.82
41
293
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
75
4.18
11.09
1.7
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
40
123
3.43
11.04
2.7
2.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
326
2432
1.88
11.00
7.3
5.7
umol/l
9.9
10.1
0.07
307
2304
(3011412) CD3 cells [#/volume] in Blood
20
36
5.73
10.77
2.1
1.8
e9/l
1.0
1.2
0.38
14
21
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
25
56
4.63
10.59
1.4
1.6
%
56.5
52.5
0.17
15
35
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
17
27
6.47
10.33
1.7
1.4
u/l
12.0
7.8
0.22
12
12
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
19
34
5.76
10.29
1.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
19
34
5.76
10.29
1.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
19
34
5.76
10.29
1.1
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
91
446
2.25
10.28
2.0
1.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
29
76
3.98
10.07
6.1
5.7
iu/ml
2574.7
193.1
—
10
10
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
71
316
2.44
9.99
2.0
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
17
28
6.24
9.98
1.9
1.8
%
26.6
11.0
—
5
13
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
72
4.05
9.98
1.6
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
70
312
2.43
9.81
2.5
2.9
e9/l
73.1
73.3
0.02
55
239
(3024980) IgG subclass 4 [Mass/volume] in Serum
26
64
4.22
9.81
1.5
1.4
g/l
0.4
0.5
0.97
19
54
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
46
166
2.94
9.76
2.0
2.1
g/l
1.5
1.6
0.50
39
143
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
90
450
2.20
9.66
2.1
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
100
526
2.11
9.43
5.4
4.4
mmol/l
1.0
1.0
0.38
93
482
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
23
6.68
9.40
1.5
1.2
ratio
1.1
1.1
—
5
8
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
18
34
5.44
9.22
1.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
35
111
3.30
9.22
1.5
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
79
383
2.25
9.12
4.0
3.5
mmol/l
1.2
1.2
0.77
72
333
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
30
87
3.59
9.05
1.3
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
102
550
2.06
8.98
1.8
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
16
28
5.86
8.85
1.4
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
106
584
2.02
8.79
1.7
2.0
ug/g
158.9
116.5
1.01
88
462
(3003396) Base excess in Arterial blood by calculation
88
453
2.13
8.74
9.5
7.5
mmol/l
0.5
1.5
1.95
71
365
(3019060) Gas panel - Arterial blood
58
251
2.47
8.65
5.7
6.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
40
4.89
8.65
1.8
1.5
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
14
22
6.51
8.57
2.4
1.7
e9/l
0.1
0.2
0.22
14
22
(3044889) 12 lead EKG panel
397
3281
1.82
8.28
5.5
3.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
9
14.76
8.24
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
99
545
2.00
8.19
1.3
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
19
42
4.65
8.18
1.4
1.3
g/l
8.2
7.5
0.11
13
33
(3028192) IgG subclass 2 [Mass/volume] in Serum
19
42
4.65
8.18
1.4
1.3
g/l
2.6
2.6
0.04
14
32
(3024139) IgG subclass 3 [Mass/volume] in Serum
19
42
4.65
8.18
1.4
1.3
g/l
0.3
0.4
0.36
13
33
(4062490)
19
42
4.65
8.18
1.4
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
56
245
2.44
8.16
8.1
8.7
mmol/l
23.9
25.1
1.47
50
235
(3001122) Ferritin [Mass/volume] in Serum or Plasma
276
2068
1.69
8.15
4.1
2.7
ug/l
79.0
98.5
2.03
256
1913
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
27
5.69
8.06
1.9
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
14
8.00
8.01
1.0
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
14
8.00
8.01
1.0
2.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
11
14
8.00
8.01
2.2
1.7
%
2.7
5.1
0.62
11
14
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
14
8.00
8.01
1.0
2.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
11
14
8.00
8.01
2.2
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
161
2.75
7.99
2.3
1.8
g/l
3.0
3.1
0.31
36
132
(40768443) Skin Pathology biopsy report
48
198
2.57
7.91
1.2
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
28
85
3.42
7.90
1.2
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
67
322
2.24
7.88
3.7
3.2
e9/l
4.2
4.0
0.38
48
255
(40761536) Microorganisms panel - Urine sediment
77
393
2.12
7.79
5.4
3.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
172
2.63
7.54
2.3
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
172
2.63
7.54
2.3
1.8
g/l
3.3
3.8
2.61
35
130
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
172
2.63
7.54
2.3
1.8
g/l
7.0
7.5
0.97
36
138
(3031040) Bacteria [#/volume] in Urine by Automated count
373
3064
1.72
7.52
5.6
4.5
e6/l
18.5
1010.7
—
6
45
(3021879) Hepatitis B virus core Ab [Presence] in Serum
64
308
2.23
7.50
1.2
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
28
88
3.30
7.50
1.5
1.2
—
—
—
0
0
(4306422)
22
59
3.85
7.43
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
33
116
2.97
7.35
1.2
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
12
19
6.44
7.27
1.2
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
50
222
2.38
7.06
2.6
2.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
201
1426
1.66
7.02
3.3
2.3
u/l
60.5
55.2
1.08
180
1310
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
14
27
5.30
7.00
1.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
35
4.68
6.97
1.3
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
151
998
1.72
6.86
7.9
4.2
kg/l
1.0
1.0
0.59
19
130
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
206
1480
1.64
6.80
4.5
2.9
u/l
31.6
29.3
0.73
198
1403
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
22
63
3.60
6.78
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
127
805
1.76
6.68
1.7
1.7
nmol/l
1209.8
1242.8
0.15
99
586
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
37
4.43
6.53
1.3
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
11
18
6.22
6.45
1.2
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
222
1642
1.60
6.42
2.6
3.4
mmol/l
2.3
2.4
1.59
192
1431
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
28
97
2.99
6.41
1.1
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
44
194
2.38
6.32
13.9
11.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
22
5.56
6.31
1.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
22
5.56
6.31
1.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
22
5.56
6.31
1.0
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
22
5.56
6.31
1.0
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
156
1071
1.65
6.04
1.6
1.5
nmol/l
23.9
22.1
0.37
133
895
(3042631) Mycobacterium sp identified in Specimen
20
60
3.42
5.77
2.6
2.8
—
—
—
0
0
(3026782) Osmolality of Urine
125
823
1.68
5.64
3.2
2.5
mosm/kgh2o
490.0
521.2
1.15
116
713
(3012095) Magnesium [Moles/volume] in Serum or Plasma
110
702
1.71
5.57
3.6
3.1
mmol/l
0.8
0.8
0.16
101
659
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
123
812
1.67
5.49
4.3
3.5
ng/l
80.0
249.0
1.23
95
599
(3002385) Erythrocyte distribution width [Ratio]
434
3841
1.70
5.35
29.4
16.1
%
14.3
13.6
15.88
434
3769
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
44
3.72
5.24
1.3
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
240
1870
1.52
5.19
2.0
1.9
pmol/l
95.4
98.5
0.37
115
872
(3026389) Candida sp identified in Specimen by Organism specific culture
21
70
3.08
5.15
1.6
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
58
311
1.97
5.13
12.0
6.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
22
76
2.98
5.09
1.4
1.4
—
—
—
0
0
(3036489) Thrombin time
35
154
2.36
5.07
2.6
1.8
s
22.9
21.3
0.38
28
138
(3013826) Glucose [Moles/volume] in Serum or Plasma
309
2552
1.50
4.96
6.6
4.3
mmol/l
6.4
6.6
0.86
299
2383
(46235355) HIV 1 and 2 tests - Meaningful Use set
102
658
1.68
4.93
1.5
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
81
491
1.77
4.89
2.8
2.4
umol/l
6.1
6.3
0.05
74
417
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
137
954
1.59
4.88
1.6
1.7
pmol/l
498.3
31305903.9
1.32
111
789
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
43
213
2.11
4.72
12.2
7.5
mmol/l
23.7
24.4
0.81
33
199
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
21
4.83
4.55
1.1
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
337
2863
1.48
4.50
2.9
3.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
195
1489
1.49
4.49
3.4
3.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
27
112
2.49
4.46
1.3
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
41
204
2.09
4.46
1.7
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
12
30
4.07
4.46
1.4
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
12
7.61
4.37
2.3
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
24
96
2.57
4.27
1.3
1.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
10
8.10
4.07
1.8
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
28
3.99
3.99
1.7
2.8
—
—
—
0
0
(3020891) Body temperature
33
159
2.15
3.91
6.3
4.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
17
60
2.89
3.82
1.5
1.3
u/ml
127.9
98.7
—
5
12
(40768441) Liver Pathology biopsy report
12
34
3.59
3.78
1.8
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
8
8.85
3.78
1.1
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
43
232
1.93
3.77
5.4
3.2
ph
7.4
7.4
—
8
37
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
122
2.28
3.73
1.3
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
26
116
2.31
3.70
1.5
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
153
1151
1.46
3.68
6.1
3.3
%
91.9
95.3
1.00
145
1115
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
41
220
1.94
3.66
5.1
3.2
mmol/l
1.9
1.8
0.04
30
169
(3019225) pH of Specimen
71
451
1.66
3.63
3.9
3.9
—
—
—
0
0
(3013512) EKG study
173
1339
1.43
3.56
4.9
3.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
423
3832
1.50
3.55
4.6
4.4
pmol/l
15.3
14.8
4.56
394
3505
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
10
26
3.90
3.53
1.8
2.0
e6/l
1617.2
775.9
—
5
10
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
18
69
2.66
3.50
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
6
6
10.09
3.50
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
6
10.09
3.50
1.0
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
12
36
3.39
3.49
1.4
1.3
e6/l
774.2
1642.6
—
6
25
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
18
5.07
3.38
1.8
1.1
umol/l
23.3
32.9
—
9
18
(44790048)
14
48
2.97
3.32
1.4
1.6
—
—
—
0
0
(44790049)
14
48
2.97
3.32
1.4
1.6
—
—
—
0
0
(44806118)
14
48
2.97
3.32
1.4
1.6
—
—
—
0
0
(44790047)
14
48
2.97
3.32
1.4
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
71
462
1.62
3.31
3.9
3.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
7
8.65
3.27
1.5
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
60
2.72
3.25
2.1
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
66
2.63
3.24
1.2
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
11
6.43
3.19
1.0
1.1
%
109.0
105.3
—
7
11
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
11
6.43
3.19
1.0
1.1
—
—
—
0
0
(3010421) pH of Blood
22
98
2.30
3.17
6.7
2.8
ph
7.4
7.4
0.57
16
78
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
32
166
1.99
3.16
2.4
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
32
167
1.97
3.11
5.4
3.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
61
388
1.65
3.11
3.0
2.5
ml/min/173m2
68.0
67.7
0.01
28
163
(40768806) Pleura Pathology biopsy report
12
39
3.12
3.10
1.4
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
56
2.73
3.08
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
15
56
2.73
3.08
3.1
3.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
11
34
3.28
3.07
1.4
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
8
7.57
3.06
3.7
8.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
8
7.57
3.06
4.3
8.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
8
7.57
3.06
1.2
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
474
4438
1.61
3.05
20.4
12.1
ml/min/173m2
80.8
81.2
0.16
438
3626
(3018677) aPTT in Platelet poor plasma by Coagulation assay
89
623
1.51
3.02
2.3
1.7
s
30.0
29.3
0.68
89
604
(21494890) Protein electrophoresis panel - 24 hour Urine
12
40
3.05
2.99
1.3
2.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
35
3.19
2.94
2.6
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
472
4423
1.59
2.93
5.6
5.2
mu/l
2.1
2.1
0.05
439
4056
(36660697) Celiac disease serology panel - Serum
61
397
1.61
2.85
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
90
2.27
2.83
1.4
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
137
1056
1.40
2.81
2.0
1.6
mg/l
1.8
1.0
0.71
116
825
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
117
877
1.43
2.81
2.2
2.8
mmol/l
2.5
2.5
0.17
104
776
(4015189)
5
6
8.40
2.75
1.4
4.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
25
125
2.05
2.75
6.0
3.7
mmol/l
3.8
3.8
0.06
25
116
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
39
227
1.77
2.75
1.8
1.6
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
6
10
6.05
2.70
1.7
1.3
mmol/l
1.5
3.1
—
6
10
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
10
6.05
2.70
1.3
1.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
12
43
2.83
2.66
1.4
1.3
g/l
28.8
33.7
0.51
12
38
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
67
2.43
2.65
1.6
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
29
157
1.90
2.57
2.1
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
18
81
2.26
2.56
3.7
2.2
%
14.1
16.2
—
10
42
(3002032) Base excess in Venous blood by calculation
55
359
1.59
2.56
4.3
3.0
mmol/l
1.4
2.2
1.01
44
288
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
88
2.20
2.54
1.6
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
52
336
1.61
2.52
2.5
2.3
ug/l
24.1
5.2
0.56
41
296
(3020961) Endomysium IgA Ab [Titer] in Serum
39
234
1.72
2.50
1.1
1.1
titre
—
89.2
—
0
6
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
26
3.50
2.49
2.7
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
26
3.50
2.49
2.7
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
20
96
2.13
2.46
2.2
3.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
90
2.15
2.41
2.7
2.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
27
3.37
2.40
2.7
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
31
176
1.81
2.39
1.8
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
29
493
0.56
2.38
1.5
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
46
2.65
2.37
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
40
247
1.67
2.32
1.5
1.4
—
—
—
0
0
(4094501)
24
127
1.93
2.30
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
67
2.27
2.19
1.3
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
25
431
0.56
2.17
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
88
2.08
2.13
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
88
2.08
2.13
1.4
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
49
2.48
2.11
2.5
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
10
5.04
2.07
2.4
1.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
10
5.04
2.07
4.2
2.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
20
3.53
2.06
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
15
298
0.49
2.05
2.2
1.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
34
210
1.66
2.00
1.4
2.4
u/l
41.7
41.2
0.06
34
188
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
30
180
1.71
1.96
5.0
2.7
mmol/l
23.2
24.5
1.55
24
162
(3009871) Measles virus Ab [Titer] in Serum
5
11
4.58
1.94
1.4
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
16
3.78
1.94
1.2
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
16
3.78
1.94
1.2
1.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
33
2.76
1.94
2.0
2.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
494
4747
1.56
1.92
21.9
14.6
mmol/l
139.3
139.8
2.72
487
4620
(40768793) Breast Pathology biopsy report
8
184
0.43
1.84
2.0
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
17
3.56
1.84
1.2
1.2
nmol/l
105.5
153.9
—
6
17
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
299
0.52
1.84
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
66
2.15
1.83
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
66
2.15
1.83
1.4
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
54
380
1.47
1.83
4.0
3.0
ng/l
79.1
73.9
0.21
45
340
(1616796) Gas panel - Central venous blood
16
80
2.03
1.81
5.7
2.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
110
1357
0.76
1.78
4.2
3.8
mg/mmol
25.0
7.3
0.78
68
763
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
67
2.12
1.77
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
67
2.12
1.77
1.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
67
2.12
1.77
1.4
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
18
3.36
1.75
4.2
5.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
29
179
1.66
1.73
2.1
2.6
u/ml
28.1
915.4
0.62
22
155
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
426
0.61
1.70
1.5
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
55
2.21
1.68
1.2
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
19
3.18
1.66
1.3
1.8
—
—
—
0
0
(1002224) Polysomnography panel
10
211
0.46
1.65
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
75
574
1.36
1.61
9.4
6.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
493
4759
1.48
1.60
22.0
14.7
mmol/l
3.9
3.9
0.08
485
4625
(40761511) CBC panel - Blood by Automated count
497
4806
1.51
1.59
22.5
12.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
144
1694
0.79
1.57
2.6
2.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
33
2.45
1.54
1.4
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
44
2.30
1.54
4.2
3.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
11
51
2.18
1.51
1.1
1.0
u/ml
0.3
2.2
—
6
16
(3017569) Oxygen content in Arterial blood
6
21
2.88
1.51
2.5
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
101
1.81
1.50
2.7
2.4
u/ml
0.3
0.4
—
8
58
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
22
2.75
1.44
1.2
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
130
1093
1.25
1.39
3.2
2.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
67
1.96
1.39
1.5
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
21
127
1.68
1.38
2.5
3.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
82
1.85
1.37
1.7
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
37
0.00
1.35
0.0
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
165
1432
1.22
1.31
3.1
2.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
18
2.79
1.28
3.2
3.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
21
130
1.64
1.28
2.0
2.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
81
650
1.29
1.27
3.0
2.7
e6/l
3.1
3.7
0.17
49
324
(3009508) Creatinine [Moles/volume] in Urine
115
1357
0.81
1.26
3.3
3.0
mmol/l
6.4
6.8
0.45
96
1126
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
36
2.24
1.24
2.8
2.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
21
132
1.62
1.22
1.4
2.6
mg/l
11.7
11.7
0.00
21
123
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
72
1.83
1.16
1.5
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
27
385
0.69
1.11
1.6
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
110
1288
0.82
1.11
3.4
3.0
mg/l
2141.4
268.5
0.95
66
726
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
236
2145
1.18
1.11
5.5
3.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
31
2.27
1.10
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
66
1.84
1.09
4.7
2.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
41
1.97
1.09
1.5
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
30
212
1.44
1.06
1.8
2.5
e6/l
0.2
0.1
0.27
30
204
(3000093) Morphology [Interpretation] in Blood Narrative
7
35
2.01
1.00
1.3
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
61
1.82
0.99
1.1
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
37
276
1.37
0.98
1.6
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
23
2.18
0.98
1.6
1.2
umol/l
10.3
19.4
—
5
23
(3004451) EKG impression Narrative
5
23
2.18
0.98
1.6
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
26
182
1.45
0.98
1.6
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
27
2.24
0.93
1.3
2.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
42
1.92
0.89
1.1
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
43
1.87
0.87
1.1
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
44
1.83
0.86
1.1
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
112
1.53
0.86
1.4
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
33
1.83
0.79
1.3
1.3
ug/l
12.2
17.7
—
6
33
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(4034850)
21
148
1.44
0.79
10.0
9.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
26
348
0.73
0.79
1.5
1.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
27
0.00
0.77
0.0
1.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
20.8
—
1779.7
—
0
28
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
14.8
—
901.4
—
0
28
(3022621) pH of Urine by Test strip
38
298
1.30
0.76
3.5
2.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
39
1.81
0.72
2.4
3.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
117
1.47
0.72
1.2
2.1
u/l
3984.3
4706.4
—
5
43
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
60
1.68
0.72
1.5
1.3
nmol/l
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
41
1.72
0.70
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
42
1.68
0.68
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
42
1.68
0.68
1.1
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
27
1.86
0.68
4.8
3.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
29
1.73
0.64
1.6
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
79
1.53
0.63
1.2
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
398
0.79
0.60
1.4
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
424
4348
0.88
0.56
4.7
5.5
mmol/mol
38.2
39.3
0.74
390
4034
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
151
1.34
0.54
1.3
1.6
—
—
—
0
0
(4010399)
42
350
1.22
0.54
1.4
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
125
1.37
0.54
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
204
0.73
0.54
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
26
205
1.28
0.53
1.4
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
39
466
0.82
0.52
1.3
1.6
%
1.6
1.4
0.87
33
412
(3005570) Glucose [Moles/volume] in Urine
7
45
1.56
0.49
2.3
3.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
25
199
1.27
0.49
3.4
2.2
%
1.0
1.1
0.65
25
199
(3019230) Fractional oxyhemoglobin in Venous blood
10
68
1.48
0.47
7.7
1.5
%
69.5
60.6
—
10
68
(4146454)
7
48
1.46
0.47
4.3
2.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
38
320
1.20
0.46
2.1
3.1
pmol/l
4.1
4.5
1.83
29
281
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
122
1322
0.90
0.45
1.6
1.7
mmol/l
1.2
1.4
1.37
95
1111
(3024928) Oxygen saturation in Venous blood
12
86
1.40
0.45
3.7
2.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
129
0.69
0.43
1.3
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
6
94
0.63
0.42
1.0
2.4
mmol/l
1.5
1.5
—
6
94
(3039443) Prostate specific Ag panel - Serum or Plasma
5
32
1.57
0.42
1.2
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
32
1.57
0.42
1.4
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
68
607
1.14
0.42
4.0
4.4
%
34.2
33.2
0.30
50
385
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
26
213
1.23
0.41
1.7
1.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
33
1.52
0.41
1.0
1.3
mmol/l
2.4
1.9
—
5
33
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
16
0.00
0.41
0.0
1.0
—
104.1
—
0
8
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
16
0.00
0.41
0.0
1.0
—
110.6
—
0
8
(3043410) Blood group antigens tested for on Red Blood Cells
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(4198724)
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
57
505
1.14
0.39
26.4
20.7
inr
1.0
1.2
—
9
69
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
2.4
6.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
126
1173
1.10
0.38
1.4
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
36
309
1.18
0.37
1.2
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
115
0.69
0.37
1.0
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
72
1.40
0.37
1.7
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
71
1.27
0.36
1.1
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
90
1.34
0.36
1.8
1.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
76
0.65
0.36
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
76
0.65
0.36
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
76
0.65
0.36
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
76
0.65
0.36
1.2
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
113
1053
1.09
0.34
1.4
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
6
46
1.31
0.33
10.7
6.6
mmol/l
6.2
6.8
—
6
35
(3044290) Cell count panel - Cerebral spinal fluid
12
93
1.30
0.30
1.2
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
65
1.23
0.27
1.4
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
91
850
1.09
0.27
1.4
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
105
1.24
0.25
2.4
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
314
3067
1.06
0.24
4.3
2.9
u/l
58.8
43.0
2.56
291
2860
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
34
378
0.89
0.22
1.1
1.2
iu/ml
62.1
162.2
—
9
166
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
453
4479
1.08
0.22
3.8
4.0
mmol/l
1.1
1.3
5.22
421
4089
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
102
0.78
0.21
3.3
4.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
22.7
—
0
12
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.5
—
2.5
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
114
0.79
0.20
1.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
115
0.78
0.20
1.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
115
0.78
0.20
1.0
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
52
1.16
0.19
2.8
1.9
pg
31.3
31.7
—
6
52
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
52
1.16
0.19
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
52
1.16
0.19
2.8
3.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
147
1.16
0.18
2.5
3.0
g/l
0.5
0.2
—
6
49
(3021387) Prolactin [Units/volume] in Serum or Plasma
15
129
1.17
0.17
1.5
1.6
mu/l
364.4
289.7
—
10
119
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
158
1.14
0.16
1.6
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
77
0.78
0.15
1.0
1.1
—
—
—
0
0
(4035726)
47
439
1.08
0.15
1.6
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
6
80
0.75
0.15
1.7
1.2
u/l
21.1
16.7
—
6
64
(42529406) Shigella sp [Presence] in Stool by Culture
18
160
1.13
0.14
1.6
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
420
4160
1.05
0.14
27.1
14.2
%
38.9
39.6
1.04
256
3007
(3016879) Cocaine [Presence] in Urine
9
106
0.85
0.13
1.0
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
16
142
1.13
0.13
1.3
1.3
miu/ml
235.8
246.7
—
6
68
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
52
493
1.06
0.12
2.3
3.8
ug/l
5.1
8.8
1.19
39
401
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
472
4748
0.95
0.12
4.6
5.0
mmol/l
2.6
2.9
7.94
442
4365
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
261
1.08
0.10
1.7
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
23
247
0.93
0.09
1.6
1.3
iu/l
34.3
33.2
0.04
17
214
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
23
214
1.08
0.08
3.0
3.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
146
1.10
0.08
1.4
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
67
1.05
0.08
1.4
1.0
—
15.6
—
0
6
(40768804) Tissue Pathology biopsy report
202
1991
1.02
0.08
2.3
2.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
11
98
1.13
0.07
7.0
1.6
nmol/l
0.8
0.8
0.00
11
79
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
34
323
1.06
0.07
3.7
4.0
%
18.5
22.0
0.69
15
145
(3023511) Choriogonadotropin [Units/volume] in Urine
6
71
0.84
0.07
1.2
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
72
0.83
0.07
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
43
413
1.04
0.07
5.0
4.5
ug/l
2.7
2.8
0.04
37
368
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
158
1.08
0.06
1.6
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
59
607
0.97
0.06
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
466
4643
1.03
0.05
4.3
4.4
mmol/l
1.6
1.6
1.87
434
4268
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
113
1.06
0.02
1.3
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21
203
1.04
0.01
2.3
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
16
155
1.03
0.00
1.8
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
116
1.04
0.00
1.8
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
34
345
0.98
0.00
1.1
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
25
247
1.01
0.00
2.3
2.7
ug/l
0.5
0.8
1.81
14
155
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
252
0.99
0.00
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
466
4659
1.00
0.00
4.3
4.5
mmol/l
4.6
4.9
5.16
436
4302
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
457
4569
1.00
0.00
4.1
4.5
mmol/l
5.5
5.9
13.63
423
4173
(3028707) Methadone [Presence] in Urine by Screen method
5
59
0.85
0.00
1.0
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
88
0.91
0.00
1.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
67
0.89
0.00
1.3
1.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
70
1.00
0.00
1.0
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.0
—
113.4
—
0
9
(44806420)
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
70
1.00
0.00
1.0
1.2
u/l
50.4
16.9
—
7
63
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
2.4
—
166.0
—
0
5
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
18.9
—
0
8
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
54
0.93
0.00
1.2
1.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
24.2
—
0
5
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
77
0.91
0.00
1.1
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint CREST and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CREST | 2.418 [2.09, 2.8] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.062 |
During the follow-up period (1.1.1998 — 31.12.2019), 370 out of 1714 females with CREST died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CREST | 2.657 [1.86, 3.8] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 88 out of 263 males with CREST died.
Mortality risk
Mortality risk for people of age
years, who have CREST.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.263% | 0.492% |
| 5 | 1.279% | 3.229% |
| 10 | 3.077% | 7.7% |
| 15 | 6.036% | 14.045% |
| 20 | 10.835% | 23.099% |
Relationships between endpoints
↥Index endpoint: CREST – CR(E)ST syndrome
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data